Insurers duly focused on policyholders’ opioid-linked claims
It immediately makes sense why drug manufacturers would seek coverage from insurers against claims that opioid-linked addictions and resulting harms spiked following their alleged downplaying of known drug risks for users.And it makes just as much sense why insurance...